Sinopharm BIBP COVID-19 vaccine
E1075979
UNEXPLORED
The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine developed by the Beijing Institute of Biological Products and widely used globally, particularly in many low- and middle-income countries, to prevent COVID-19.
All labels observed (3)
| Label | Occurrences |
|---|---|
| Sinopharm BIBP COVID-19 vaccine canonical | 1 |
| Sinopharm COVID-19 vaccine | 1 |
| Sinopharm WIBP COVID-19 vaccine | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T13959223 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Sinopharm BIBP COVID-19 vaccine Context triple: [Sinopharm, distributes, Sinopharm BIBP COVID-19 vaccine]
-
A.
CoronaVac
CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
-
B.
Sputnik V COVID-19 vaccine
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
-
C.
Sinovac
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
D.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
E.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Sinopharm BIBP COVID-19 vaccine Target entity description: The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine developed by the Beijing Institute of Biological Products and widely used globally, particularly in many low- and middle-income countries, to prevent COVID-19.
-
A.
CoronaVac
CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
-
B.
Sputnik V COVID-19 vaccine
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
-
C.
Sinovac
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
D.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
E.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
- F. None of above. chosen
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Sinopharm WIBP COVID-19 vaccine